Detalhe da pesquisa
1.
Validation of the RHL30 digital gene expression assay as a prognostic biomarker for relapsed Hodgkin lymphoma.
Br J Haematol
; 190(6): 864-868, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32510594
2.
How Wide Should Margins Be for Phyllodes Tumors of the Breast?
Breast J
; 23(3): 315-322, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-27901301
3.
Marginal zone lymphoma transdifferentiated to histiocytic sarcoma.
Br J Haematol
; 194(6): 1090-1094, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34096049
4.
Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma.
Haematologica
; 106(5): 1466-1471, 2021 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32817292
5.
Concurrent JAK2 mutation and isolated del(5q) associated with marrow fibrosis and small hypo/monolobated megakaryocytes.
Blood
; 132(1): 112, 2018 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29976782
6.
Breast implant-associated EBV-positive diffuse large B-cell lymphoma: Two case reports and literature review.
Pathol Res Pract
; 226: 153589, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34455365
7.
DNA Methylation-Based Classification of Small B-Cell Lymphomas: A Proof-of-Principle Study.
J Mol Diagn
; 23(12): 1774-1786, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34562613
8.
Role of CD47 in Hematological Malignancies.
J Hematol Oncol
; 13(1): 96, 2020 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32677994
9.
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway.
J Hematol Oncol
; 11(1): 46, 2018 03 27.
Artigo
Inglês
| MEDLINE | ID: mdl-29580288
10.
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies.
Biomark Res
; 6: 34, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30555699
11.
RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia.
Leuk Res
; 111: 106735, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34735933
12.
Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab.
Anticancer Res
; 33(6): 2569-76, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23749910